{"url_path":"/sec/elv/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1156039/0001156039-26-000058-index.html","accession_number":"0001156039-26-000058","cik":"0001156039","ticker":"ELV","issuer_name":"Elevance Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1156039/0001156039-26-000058-index.html","primary_entity_key":"0001156039","primary_entity_name":"Elevance Health, Inc."},"word_count":100,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.\n\nExhibit\n\n99.1\n\n[Press Release, dated](a2q2026elvearningsrelease.htm)[Ju](a2q2026elvearningsrelease.htm)[ly 15](a2q2026elvearningsrelease.htm)[, 2026, reporting Elevance Health, Inc. financial results for the quarter ended](a2q2026elvearningsrelease.htm)[June 30](a2q2026elvearningsrelease.htm)[, 2026.](a2q2026elvearningsrelease.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 15th day of July, 2026.\n\nELEVANCE HEALTH, INC.\n\nBy:\n\n/s/ Kathleen S. Kiefer\n\nName:\n\nKathleen S. Kiefer\n\nTitle:\n\nChief Governance Officer and Corporate Secretary"}